Furthermore, a high CD8+/CD4 + ratio and low FOXP3/CD8 ratio correlate to longer survival of stromal PD-L1 + patients, but not that of stromal PD-L1 − patients with esophageal cancer [40]. Here, CD8A is linked to esophageal cancer.